首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1522904

全球快速微生物檢測市場規模、佔有率和成長分析：按產品、按應用、按方法、按地區 - 產業預測，2024-2031 年

Global Rapid Microbiology Testing Market Size, Share, Growth Analysis, By Product, By Application, By Method, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月10日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，全球快速微生物檢測市場規模為42億美元，從2023年的45.9億美元增加至2031年的94.3億美元，複合年成長率預計為9.4%。

由於幾個關鍵因素，全球快速微生物檢測市場正在經歷強勁成長。其主要驅動力是人們對食品安全的日益關注，推動了對可靠檢測方法的需求。技術的進步以及公共和私營部門投資的增加進一步支持了市場的擴張。另一個重要趨勢是擴大使用微生物檢測來診斷人類感染疾病，這凸顯了早期、準確的疾病檢測的必要性。研究活動的活性化，加上感染疾病率的上升和持續的技術創新，正在推動市場的快速發展。此外，政府致力於檢測抗菌素抗藥性的努力正在創造新的機會，特別是在新興經濟體。此外，全球對生物恐怖主義監測的關注正在為全球快速微生物檢測市場開闢新的前景。這些多樣化的成長軌跡凸顯了該市場在解決全球對食品安全、感染疾病和增強診斷能力的擔憂方面發揮的關鍵作用。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Thermo Fisher Scientific Inc.（United States）
bioMerieux SA（France）
Danaher Corporation（United States）
Merck KGaA（Germany）
Becton, Dickinson and Company（United States）
3M Company（United States）
Abbott Laboratories（United States）
Bruker Corporation（United States）
Neogen Corporation（United States）
Quidel Corporation（United States）
Eurofins Scientific（Luxembourg）
F. Hoffmann-La Roche Ltd（Switzerland）
Cepheid Inc.（United States）
Bio-Rad Laboratories, Inc.（United States）
Pall Corporation（United States）
BioFire Diagnostics, LLC（United States）
MilliporeSigma（United States）
Agilent Technologies, Inc.（United States）
Accelerate Diagnostics, Inc.（United States）
Luminex Corporation（United States）

簡介目錄

Product Code: SQMIG35A2782

Rapid Microbiology Testing Market size was valued at USD 4.20 billion in 2022 and is poised to grow from USD 4.59 billion in 2023 to USD 9.43 billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

The rapid microbiology testing market is experiencing robust growth due to several pivotal factors. Primary among these is the growing concern over food safety, which is boosting the demand for reliable testing methodologies. Technological advancements and increased investments from both public and private sectors are further bolstering market expansion. Another significant trend is the rising use of microbiology testing in diagnosing infectious diseases in humans, underscoring the need for early and accurate disease detection. Increased research activities, combined with rising incidences of infectious diseases and ongoing technological innovations, are driving rapid market evolution. Moreover, government initiatives, particularly in emerging economies, focusing on detecting antimicrobial resistance are creating new opportunities. Additionally, global attention on bioterrorism surveillance is opening up fresh prospects for the rapid microbiology testing market in the foreseeable future. This diverse growth trajectory highlights the market's pivotal role in addressing global concerns related to food safety, infectious diseases, and enhancing diagnostic capabilities worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Rapid Microbiology Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Rapid Microbiology Testing Market Segmental Analysis

Rapid Microbiology Testing Market is segmented on the basis of product, method, application, and region. Based on product, the market is segmented into Instruments (Automated Microbial Identification & Antimicrobial Susceptibility Testing System, Mass Spectrometers, PCR Systems, Bioluminescence & Fluorescence Based Detection Systems, Cytometers, Active Air Samplers, and Other Instruments), Reagents & Kits (Sterility Testing, Other Reagents & Kits), and Consumables. Based on method, the market is segmented into Growth-based Rapid Microbiology Testing, Cellular Component -based Rapid Microbiology Testing, Nucleic Acid -based Rapid Microbiology Testing, Viability -based Rapid Microbiology Testing, Other Rapid Microbiology Testing. Based on application, the market is segmented into Industrial Testing (Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, Environmental Testing, Cosmetics & Personal Care Products Testing, Other Industrial Testing Applications), Clinical Disease Diagnosis, and Research Applications. Based on Region, the market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Drivers of the Rapid Microbiology Testing Market

The increase in infectious diseases worldwide, including global epidemics and pandemics like Pneumonia, has significantly boosted the demand for diagnostic tests. This rise in disease prevalence has heightened public consciousness and underscored the importance of early detection. Consequently, there is a growing recognition of the vital role diagnostic tests play in identifying and managing infectious diseases, driving a notable surge in demand for these tools. This heightened awareness, combined with proactive measures for early disease identification, is expected to fuel substantial growth in the diagnostic testing industry in the foreseeable future.

Restraints in the Rapid Microbiology Testing Market

The advancement of diagnostic tests, especially for cancer and infectious diseases, requires significant financial commitment, primarily to adhere to stringent regulatory standards. The dynamic field of diagnostic technologies and increasingly rigorous regulatory criteria necessitate substantial financial backing at every stage of clinical trials. The intensified regulatory oversight and the imperative to meet stringent criteria introduce delays in development, thereby demanding substantial investments to successfully navigate clinical trials complexities and obtain necessary regulatory endorsements.

Market Trends of the Rapid Microbiology Testing Market

Emerging economies like India, South Korea, Brazil, and Mexico offer significant growth opportunities for market participants. These markets are appealing due to several factors: high disease prevalence, large patient bases, improving healthcare infrastructure, increasing disposable incomes, and a growing trend in medical tourism. The substantial disease burden in these regions highlights the demand for advanced healthcare solutions, encompassing both diagnostic and therapeutic innovations. Ongoing enhancements in healthcare infrastructure also promote the uptake of new medical technologies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Global Rapid Microbiology Testing Market by Product

Market Overview
Instruments
- Automated Microbial Identification & Antimicrobial Susceptibility Testing System
- Mass Spectrometers
- PCR Systems
- Bioluminescence & Fluorescence Based Detection Systems
- Cytometers
- Active Air Systems
- Others
Reagents & Kits
- Sterility Testing & Kits
- Other Reagents & Kits
Consumables

Global Rapid Microbiology Testing Market by Application

Market Overview
Clinical Disease Diagnosis
Food and Beverage Testing
Pharmaceutical and Biological Drug Testing
Environmental Testing
Cosmetics and Personal Care Products Testing
Research Applications
Othersa

Global Rapid Microbiology Testing Market by Method

Market Overview
Growth-based Rapid Microbiology Testing
Cellular Component -based Rapid Microbiology Testing
Nucleic Acid -based Rapid Microbiology Testing
Viability -based Rapid Microbiology Testing
Other Rapid Microbiology Testing

Global Rapid Microbiology Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pall Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioFire Diagnostics, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MilliporeSigma (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accelerate Diagnostics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments